{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:59:15Z","timestamp":1760299155441,"version":"3.37.3"},"reference-count":41,"publisher":"Wiley","issue":"13","license":[{"start":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T00:00:00Z","timestamp":1433462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T00:00:00Z","timestamp":1433462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Public Health Service","award":["P01 CA108964","U10 CA37429","UM1 CA182883","P30 CA054174","P30 CA006973"],"award-info":[{"award-number":["P01 CA108964","U10 CA37429","UM1 CA182883","P30 CA054174","P30 CA006973"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["T32 CA009314"],"award-info":[{"award-number":["T32 CA009314"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostate"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1002\/pros.23021","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T13:26:33Z","timestamp":1433510793000},"page":"1403-1418","source":"Crossref","is-referenced-by-count":24,"title":["Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial"],"prefix":"10.1002","volume":"75","author":[{"given":"Danyelle A.","family":"Winchester","sequence":"first","affiliation":[{"name":"Department of Epidemiology; Johns Hopkins Bloomberg School of Public Health; Baltimore Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathee","family":"Till","sequence":"additional","affiliation":[{"name":"SWOG Statistical Center; Fred Hutchinson Cancer Research Center; Seattle Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis J.","family":"Goodman","sequence":"additional","affiliation":[{"name":"SWOG Statistical Center; Fred Hutchinson Cancer Research Center; Seattle Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M.","family":"Tangen","sequence":"additional","affiliation":[{"name":"SWOG Statistical Center; Fred Hutchinson Cancer Research Center; Seattle Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina M.","family":"Santella","sequence":"additional","affiliation":[{"name":"Department of Environmental Health Sciences, Mailman School of Public Health; Columbia University; New York New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa L.","family":"Johnson-Pais","sequence":"additional","affiliation":[{"name":"Department of Urology; University of Texas Health Science Center San Antonio; San Antonio Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin J.","family":"Leach","sequence":"additional","affiliation":[{"name":"Department of Urology; University of Texas Health Science Center San Antonio; San Antonio Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Xu","sequence":"additional","affiliation":[{"name":"Program for Personalized Cancer Care and Department of Surgery; NorthShore University Health System; Evanston Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Lilly","family":"Zheng","sequence":"additional","affiliation":[{"name":"Program for Personalized Cancer Care and Department of Surgery; NorthShore University Health System; Evanston Illinois"},{"name":"Center for Cancer Genomics; Wake Forest University School of Medicine; Winston-Salem North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Urology; University of Texas Health Science Center San Antonio; San Antonio Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Scott","family":"Lucia","sequence":"additional","affiliation":[{"name":"Department of Pathology; University of Colorado Denver School of Medicine; Aurora Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott M.","family":"Lippmann","sequence":"additional","affiliation":[{"name":"Moores Cancer Center; University of California San Diego; La Jolla California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard L.","family":"Parnes","sequence":"additional","affiliation":[{"name":"Prostate and Urologic Cancer Research Group; Division of Cancer Prevention, National Cancer Institute; Bethesda Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Dluzniewski","sequence":"additional","affiliation":[{"name":"Department of Epidemiology; Johns Hopkins Bloomberg School of Public Health; Baltimore Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William B.","family":"Isaacs","sequence":"additional","affiliation":[{"name":"Department of Urology, and James Buchanan Brady Urological Institute; Johns Hopkins University School of Medicine; Baltimore Maryland"},{"name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Baltimore Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo M.","family":"De Marzo","sequence":"additional","affiliation":[{"name":"Department of Urology, and James Buchanan Brady Urological Institute; Johns Hopkins University School of Medicine; Baltimore Maryland"},{"name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Baltimore Maryland"},{"name":"Department of Pathology; Johns Hopkins University School of Medicine; Baltimore Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles G.","family":"Drake","sequence":"additional","affiliation":[{"name":"Department of Urology, and James Buchanan Brady Urological Institute; Johns Hopkins University School of Medicine; Baltimore Maryland"},{"name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Baltimore Maryland"},{"name":"Department of Immunology; Johns Hopkins University School of Medicine; Baltimore Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Platz","sequence":"additional","affiliation":[{"name":"Department of Epidemiology; Johns Hopkins Bloomberg School of Public Health; Baltimore Maryland"},{"name":"Department of Urology, and James Buchanan Brady Urological Institute; Johns Hopkins University School of Medicine; Baltimore Maryland"},{"name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Baltimore Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,6,5]]},"reference":[{"key":"10.1002\/pros.23021-BIB0001|pros23021-cit-0001","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2559.2011.04033.x","article-title":"Prostate cancer and inflammation: The evidence","volume":"60","author":"Sfanos","year":"2012","journal-title":"Histopathology"},{"key":"10.1002\/pros.23021-BIB0002|pros23021-cit-0002","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1055-9965.EPI-13-1126","article-title":"Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial","volume":"23","author":"Gurel","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/pros.23021-BIB0003|pros23021-cit-0003","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1002\/pros.23021-BIB0004|pros23021-cit-0004","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/pros.20496","article-title":"A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study","volume":"66","author":"Zheng","year":"2006","journal-title":"Prostate"},{"key":"10.1002\/pros.23021-BIB0005|pros23021-cit-0005","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJMoa075819","article-title":"Cumulative association of five genetic variants with prostate cancer","volume":"358","author":"Zheng","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1002\/pros.23021-BIB0006|pros23021-cit-0006","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/pros.21208","article-title":"Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic variation","volume":"70","author":"Kim","year":"2010","journal-title":"Prostate"},{"key":"10.1002\/pros.23021-BIB0007|pros23021-cit-0007","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/pros.21235","article-title":"Meta-analysis of genome-wide and replication association studies on prostate cancer","volume":"71","author":"Liu","year":"2011","journal-title":"Prostate"},{"key":"10.1002\/pros.23021-BIB0008|pros23021-cit-0008","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/ng0908-1032","article-title":"Variation in KLK genes, prostate-specific antigen and risk of prostate cancer","volume":"40","author":"Ahn","year":"2008","journal-title":"Nat Genet"},{"key":"10.1002\/pros.23021-BIB0009|pros23021-cit-0009","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/pros.20908","article-title":"Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer","volume":"69","author":"Wiklund","year":"2009","journal-title":"Prostate"},{"key":"10.1002\/pros.23021-BIB0010|pros23021-cit-0010","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/scitranslmed.3001513","article-title":"Genetic correction of PSA values using sequence variants associated with PSA levels","volume":"2","author":"Gudmundsson","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1002\/pros.23021-BIB0011|pros23021-cit-0011","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1158\/1940-6207.CAPR-09-0256","article-title":"Transition of a clinical trial into translational research: The prostate cancer prevention trial experience","volume":"3","author":"Goodman","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1002\/pros.23021-BIB0012|pros23021-cit-0012","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/pros.20933","article-title":"Association of IL10 and Other immune response- and obesity-related genes with prostate cancer in CLUE II","volume":"69","author":"Wang","year":"2009","journal-title":"Prostate"},{"key":"10.1002\/pros.23021-BIB0013|pros23021-cit-0013","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1158\/1055-9965.EPI-12-0458","article-title":"Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence","volume":"21","author":"Dluzniewski","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/pros.23021-BIB0014|pros23021-cit-0014","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/pcan.2011.6","article-title":"IL-10 polymorphisms and prostate cancer risk: A meta-analysis","volume":"14","author":"Shao","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1002\/pros.23021-BIB0015|pros23021-cit-0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/omi.2012.0089","article-title":"The interleukin 10-819C\/T polymorphism and cancer risk: A HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls","volume":"17","author":"Yu","year":"2013","journal-title":"OMICS"},{"key":"10.1002\/pros.23021-BIB0016|pros23021-cit-0016","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10552-007-9077-6","article-title":"Association of IL-10 polymorphisms with prostate cancer risk and grade of disease","volume":"19","author":"Faupel-Badger","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1002\/pros.23021-BIB0017|pros23021-cit-0017","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000251189","article-title":"Influence of cytokine gene polymorphisms on prostate-specific antigen recurrence in prostate cancer after radical prostatectomy","volume":"83","author":"Lin","year":"2009","journal-title":"Urol Int"},{"key":"10.1002\/pros.23021-BIB0018|pros23021-cit-0018","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000209829","article-title":"Interlukin-10, interferon-\u03b3 and tumor necrosis factor-\u03b1 genes variation in prostate cancer and benign prostatic hyperplasia","volume":"2","author":"Omrani","year":"2008","journal-title":"Curr Urol"},{"key":"10.1002\/pros.23021-BIB0019|pros23021-cit-0019","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/carcin\/bgm277","article-title":"Interactions of cytokine gene polymorphisms in prostate cancer risk","volume":"29","author":"Zabaleta","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1002\/pros.23021-BIB0020|pros23021-cit-0020","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/1471-2407-10-456","article-title":"Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese","volume":"10","author":"Liu","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1002\/pros.23021-BIB0021|pros23021-cit-0021","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ejca.2010.11.034","article-title":"Lack of association of IL-10 gene polymorphisms with prostate cancer: Evidence from 11,581 subjects","volume":"47","author":"Zou","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1002\/pros.23021-BIB0022|pros23021-cit-0022","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/mutage\/ger078","article-title":"The interleukin-10-1082 promoter polymorphism and cancer risk: A meta-analysis","volume":"27","author":"Wang","year":"2012","journal-title":"Mutagenesis"},{"key":"10.1002\/pros.23021-BIB0023|pros23021-cit-0023","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1158\/1055-9965.EPI-05-0356","article-title":"The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk","volume":"14","author":"Xu","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/pros.23021-BIB0024|pros23021-cit-0024","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1158\/1055-9965.EPI-08-0981","article-title":"Toll-like receptor signaling pathway variants and prostate cancer mortality","volume":"18","author":"Stark","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/pros.23021-BIB0025|pros23021-cit-0025","first-page":"3369","article-title":"Influence of cytokine gene polymorphisms on the development of prostate cancer","volume":"62","author":"McCarron","year":"2002","journal-title":"Cancer Res"},{"key":"10.1002\/pros.23021-BIB0026|pros23021-cit-0026","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1007\/s11033-011-1042-5","article-title":"-251 T\/A polymorphism of the interleukin-8 gene and cancer risk: A HuGE review and meta-analysis based on 42 case-control studies","volume":"39","author":"Wang","year":"2012","journal-title":"Mol Biol Rep"},{"key":"10.1002\/pros.23021-BIB0027|pros23021-cit-0027","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.cej.0000199504.07947.e7","article-title":"Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial","volume":"15","author":"Yang","year":"2006","journal-title":"Eur J Cancer Prev"},{"key":"10.1002\/pros.23021-BIB0028|pros23021-cit-0028","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1158\/0008-5472.CAN-05-3987","article-title":"Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer","volume":"66","author":"Michaud","year":"2006","journal-title":"Cancer Res"},{"key":"10.1002\/pros.23021-BIB0029|pros23021-cit-0029","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s10552-010-9571-0","article-title":"Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk","volume":"21","author":"Zhang","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1002\/pros.23021-BIB0030|pros23021-cit-0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/ng1021","article-title":"RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases","volume":"32","author":"Casey","year":"2002","journal-title":"Nat Genet"},{"key":"10.1002\/pros.23021-BIB0031|pros23021-cit-0031","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1158\/1055-9965.EPI-04-0637","article-title":"Association of susceptibility alleles in ELAC2\/HPC2, RNASEL\/HPC1, and MSR1 with prostate cancer severity in European American and African American men","volume":"14","author":"Rennert","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/pros.23021-BIB0032|pros23021-cit-0032","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/pros.21207","article-title":"Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population","volume":"70","author":"Agalliu","year":"2010","journal-title":"Prostate"},{"key":"10.1002\/pros.23021-BIB0033|pros23021-cit-0033","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/pros.21370","article-title":"Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study","volume":"71","author":"Fesinmeyer","year":"2011","journal-title":"Prostate"},{"key":"10.1002\/pros.23021-BIB0034|pros23021-cit-0034","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1158\/1055-9965.EPI-08-1223","article-title":"Genetic variants and prostate cancer risk: Candidate replication and exploration of viral restriction genes","volume":"18","author":"Breyer","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/pros.23021-BIB0035|pros23021-cit-0035","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/carcin\/bgq132","article-title":"Genetic variation in RNASEL associated with prostate cancer risk and progression","volume":"31","author":"Meyer","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1002\/pros.23021-BIB0036|pros23021-cit-0036","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1007\/s11033-010-0657-2","article-title":"RNASEL -1385G\/A polymorphism and cancer risk: A meta-analysis based on 21 case-control studies","volume":"38","author":"Zhang","year":"2011","journal-title":"Mol Biol Rep"},{"key":"10.1002\/pros.23021-BIB0037|pros23021-cit-0037","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jcmm.12171","article-title":"Association of RNASEL and 8q24 variants with the presence and aggressiveness of hereditary and sporadic prostate cancer in a Hispanic population","volume":"18","author":"San Francisco","year":"2014","journal-title":"J Cell Mol Med"},{"key":"10.1002\/pros.23021-BIB0038|pros23021-cit-0038","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.7314\/APJCP.2014.15.7.3129","article-title":"rs10505474 and rs7837328 at 8q24 cumulatively confer risk of prostate cancer in Northern Han Chinese","volume":"15","author":"Zhang","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1002\/pros.23021-BIB0039|pros23021-cit-0039","first-page":"575","article-title":"Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort","volume":"10","author":"Xue","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/pros.23021-BIB0040|pros23021-cit-0040","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/01.ju.0000168723.42824.40","article-title":"Interleukin-6 polymorphism is associated with more aggressive prostate cancer","volume":"174","author":"Tan","year":"2005","journal-title":"J Urol"},{"key":"10.1002\/pros.23021-BIB0041|pros23021-cit-0041","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1158\/1055-9965.EPI-14-0863","article-title":"Polymorphisms influencing prostate-specific antigen concentration may bias genome-wide association studies on prostate cancer","volume":"24","author":"Dluzniewski","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.23021","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.23021","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pros.23021\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T05:06:09Z","timestamp":1625461569000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pros.23021"}},"subtitle":["Immune Response Genes and Prostate Cancer Risk"],"short-title":[],"issued":{"date-parts":[[2015,6,5]]},"references-count":41,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2015,9]]}},"URL":"https:\/\/doi.org\/10.1002\/pros.23021","archive":["Portico"],"relation":{},"ISSN":["0270-4137"],"issn-type":[{"type":"print","value":"0270-4137"}],"subject":[],"published":{"date-parts":[[2015,6,5]]}}}